R-ketorolac inhibitor was identified in a study on immortalized human ovarian adenocarcinoma cells (SKOV-3ip) and primary patient-derived ovarian cancer cells with similar effects to those of small molecule inhibitors of Rac1 (NSC23766) and Cdc42 (CID2950007/ML141). Here, CDC42 is linked to ovarian carcinoma.